α-酮异己酸的生物合成研究进展

doi:10.16085/j.issn.1000-6613.2018-0193

摘要/Abstract

摘要： α-酮异己酸是重要有机酸、药用氨基酸合成前体、新陈代谢调节因子和治疗药物，其生物合成路径条件温和，环境友好。本文对α-酮异己酸的生理功能和体内代谢机理进行了归纳，并着重对其生物合成路径的研究进展进行了综述。现有研究表明，α-酮异己酸可用葡萄糖为底物，通过代谢工程改造的谷氨酸棒杆菌或大肠杆菌工程菌发酵合成，但产物浓度较低；或以L-亮氨酸为底物，经氨基酸转氨酶、氧化酶、脱氨酶、重组工程菌或全细胞催化转化合成，产物浓度较高。α-酮异己酸高产菌株的筛选、利用代谢工程方法对菌株进行改造以构建高效工程菌、发酵与分离提取工艺优化等问题，是今后需要研究的重点。

关键词: &alpha, -酮异己酸, 生物合成, 代谢工程

Abstract: α-Ketoisocaproate (KIC) is not only an important organic acid and key precursor of branched chain amino acids for pharmaceuticals, but also a metabolic regulator and therapeutic agent. Biosynthesis pathway for the production of KIC has advantages of the mild reaction conditions and environment-friendly processes. In this work, the advances of the important physiological properties, the metabolisms and the biosynthetic pathways of KIC, were summarized. According to the references, two biosynthetic pathways are available for the preparation of KIC. The first one is the microbial fermentation approach using the strains of Corynebacterium glutamicum by metabolic engineering or recombinant Escherichia coli with glucose as the substrate, where the yield is low. The another is the enzymatic catalyzing using amino acid aminotransferases, oxidases or deaminases, the whole-cell bioconversion and the recombinant engineering strains using L-leucine as the substrate, where the yield is slightly high. Issues regarding the metabolic engineering improvement of the yield of KIC, the biosynthesis pathway, and the advanced fermentation and separation techniques, were proposed and considered as the important future research directions.

Key words: α-ketoisocaproate, biosynthesis, metabolic engineering

中图分类号:

Q939.97

程申, 张颂红, 贠军贤. α-酮异己酸的生物合成研究进展[J]. 化工进展, 2018, 37(12): 4821-4829.

CHENG Shen, ZHANG Songhong, YUN Junxian. Recent advances in microbial synthesis of α-ketoisocaproate[J]. Chemical Industry and Engineering Progress, 2018, 37(12): 4821-4829.

参考文献

[1] ZHU Y H, LI J, LIU L, et al. Production of α-ketoisocaproate via free-whole-cell biotransformation by Rhodococcus opacus DSM 43250 with L-leucine as the substrate[J]. Enzyme and Microbial Technology, 2011, 49(4):321.
[2] VOGT M, HAAS S, POLEN T, et al. Production of 2-ketoisocaproate with Corynebacterium glutamicum strains devoid of plasmids and heterologous genes[J]. Microbial Biotechnology, 2015, 8(2):351-360.
[3] 祝玉洪, 刘龙, 周景文, 等. 不透明红球菌转化合成α-酮异己酸的培养条件优化[J]. 应用与环境生物学报, 2011, 17(4):553-557. ZHU Yuhong, LIU Long, ZHOU Jingwen, et al. Optimization of transformation and synthesis conditions of α-ketoisocaproate by Rhodococcus opacus DSM 43250[J]. Chinese Journal of Applied and Environmental Biology, 2011, 17(4):553-557.
[4] 程开花, 徐宏斌, 史丹丹, 等. α-酮酸及其盐的合成研究进展[J]. 现代生物医学进展, 2009, 9(6):1168-1170. CHENG Kaihua, XU Hongbin, SHI Dandan, et al. Research progress on synthesis of α-keto acid and its salts[J]. Progress in Modern Biomedicine, 2009, 9(6):1168-1170.
[5] BÜCKLE-VALLANT V, KRAUSE F S, MESSERSCHMIDT S, et al. Metabolic engineering of Corynebacterium glutamicum for 2-ketoisocaproate production[J]. Applied Microbiology and Biotechnology, 2014, 98(1):297-311.
[6] BARAZZONI R, MEEK S E, EKBERG K, et al. Arterial KIC as marker of liver and muscle intracellular leucine pools in healthy and type 1 diabetic humans[J]. American Journal of Physiology, 1999, 277(2):E238.
[7] ZANCHI N E, GERLINGER R F, GUIMARAES F L, et al. HMB supplementation:clinical and athletic performance-related effects and mechanisms of action[J]. Amino Acids, 2011, 40(4):1015-1025.
[8] ESCOBAR J, FRANK J W, SURYAWAN A, et al. Leucine and α-ketoisocaproic acid, but not norleucine, stimulate skeletal muscle protein synthesis in neonatal pigs[J]. Journal of Nutrition, 2010, 140(8):1418.
[9] FLAKOLL P J, VANDEHAAR M J, KUHLMAN G, et al. Influence of α-ketoisocaproate on lamb growth feed conversion and carcass composition[J]. Journal of Animal Science, 1991, 69(4):1461.
[10] BELLIZZI V, CHIODINI P, CUPISTI A, et al. Very low-protein diet plus ketoacids in chronic kidney disease and risk of death during end-stage renal disease:a historical cohort controlled study[J]. Nephrology Dialysis Transplantation, 2015, 30(1):71-7.
[11] CHANG J H, KIM D K, PARK J T, et al. Influence of ketoanalogs supplementation on the progression in chronic kidney disease patients who had training on low-protein diet[J]. Nephrology, 2009, 14(8):750-757.
[12] FOUQUE D, CHEN J, CHEN W, et al. Adherence to ketoacids/essential amino acids-supplemented low protein diets and new indications for patients with chronic kidney disease[J]. BMC Nephrology, 2016, 17(1):1-5.
[13] LECLERCQ-MEYER V, MARCHAND J, LECLERCQ R, et al. Interactions of α-ketoisocaproate, glucose and arginine in the secretion of glucagon and insulin from the perfused rat pancreas[J]. Diabetologia, 1979, 17(2):121.
[14] HEISSIG H, URBAN K A, HASTEDT K, et al. Mechanism of the insulin-releasing action of α-ketoisocaproate and related α-keto acid anions[J]. Molecular Pharmacology, 2005, 68(4):1097.
[15] ZHOU Y, JETTON T L, GOSHORN S, et al. Transamination is required for α-ketoisocaproate but not leucine to stimulate insulin secretion[J]. Journal of Biological Chemistry, 2010, 285(44):33718-33726.
[16] DICKINSON J R, LANTERMAN M M, DANNER D J, et al. A ¹³C nuclear magnetic resonance investigation of the metabolism of leucine to isoamyl alcohol in Saccharomyces cerevisiae[J]. Journal of Biological Chemistry, 1997, 272(43):26871-26878.
[17] NISSEN S L, ABUMRAD N N. Nutritional role of the leucine metabolite β-hydroxy β-methylbutyrate (HMB)[J]. Journal of Nutritional Biochemistry, 1997, 8(6):300-311.
[18] 乔璇, 张海军, 齐广海, 等. β-羟基-β-丁酸甲酯调控肌肉代谢的研究进展[J]. 动物营养学报, 2011, 23(12):2064-2070. QIAO Xuan, ZHANG Haijun, QI Guanghai, et al. Recent advances in β-hydroxy-β-methylbutyrate regulating muscle metabolism[J]. Chinese Journal of Animal Nutrition, 2011, 23(12):2064-2070.
[19] WILSON G J, WILSON J M, MANNINEN A H. Effects of beta-hydroxy-beta-methylbutyrate (HMB) on exercise performance and body composition across varying levels of age, sex, and training experience:a review[J]. Nutrition and Metabolism, 2008, 5(1):1.
[20] SHREERAM S, RAMESH S, PUTHAN J K, et al. Age associated decline in the conversion of leucine to β-hydroxy-β-methylbutyrate in rats[J]. Experimental Gerontology, 2016, 80:6-11.
[21] VAN K M, NISSEN S. Oxidation of leucine and alpha-ketoisocaproate to beta-hydroxy-beta-methylbutyrate in vivo[J]. American Journal of Physiology, 1992, 262(1):E27.
[22] 堵国成, 宋阳, 刘龙, 等. α-酮酸的合成方法及应用研究[J]. 食品与生物技术学报, 2013, 32(11):1121-1127. DU Guocheng, SONG Yang, LIU Long, et al. Advances in production and application of α-keto acids[J]. Journal of Food Science and Biotechnology, 2013, 32(11):1121-1127.
[23] SONG Y, LI J, SHIN H D, et al. Biotechnological production of alpha-keto acids:current status and perspectives[J]. Bioresource Technology, 2016, 219:716-724.
[24] LEYVAL D, UY D, DELAUNAY S, et al. Characterisation of the enzyme activities involved in the valine biosynthetic pathway in a valine-producing strain of Corynebacterium glutamicum[J]. Journal of Biotechnology, 2003, 104(1/2/3):241-252.
[25] HOLATKO J, ELISAKOVA V, PROUZA M, et al. Metabolic engineering of the L-valine biosynthesis pathway in Corynebacterium glutamicum using promoter activity modulation[J]. Journal of Biotechnology, 2009, 139(3):203.
[26] CHEN C, LI Y, HU J, et al. Metabolic engineering of Corynebacterium glutamicum ATCC13869 for L-valine production[J]. Metabolic Engineering, 2015, 29:66.
[27] VOGT M, HAAS S, KLAFFL S, et al. Pushing product formation to its limit:metabolic engineering of Corynebacterium glutamicum for L-leucine overproduction[J]. Metabolic Engineering, 2014, 22(3):40.
[28] PATEK M, KRUMBACH K, EGGELING L, et al. Leucine synthesis in Corynebacterium glutamicum:enzyme activities, structure of leuA, and effect of leuA inactivation on lysine synthesis[J]. Applied and Environmental Microbiology, 1994, 60(1):133.
[29] BRUNE I, JOCHMANN N, BRINKROLF K, et al. The IclR-type transcriptional repressor LtbR regulates the expression of leucine and tryptophan biosynthesis genes in the amino acid producer Corynebacterium glutamicum[J]. Journal of Bacteriology, 2007, 189(7):2720.
[30] MADSEN S M, BECK H C, RAVN P, et al. Cloning and inactivation of a branched-chain-amino-acid aminotransferase gene from Staphylococcus carnosus and characterization of the enzyme[J]. Applied and Environmental Microbiology, 2002, 68(8):4007-4014.
[31] FREIDING S, EHRMANN M A, VOGEL R F. Comparison of different IlvE aminotransferases in Lactobacillus sakei and investigation of their contribution to aroma formation from branched chain amino acids[J]. Food Microbiology, 2012, 29(2):205-214.
[32] LIU L, LI J, FANG J, et al. Process modeling and optimization of whole-cell biotransformation synthesis of α-ketoisocaproate by Bacillus cereus producing branched-chain amino acid aminotransferase with artificial neural network coupling genetic algorithm[J]. Journal of Bioscience and Bioengineering, 2009, 108:S127-S128.
[33] TAYLOR P P, PANTALEONE D P, SENKPEIL R F, et al. Novel biosynthetic approaches to the production of unnatural amino acids using transaminases[J]. Trends in Biotechnology, 1998, 16(10):412.
[34] STUMPF P K, GREEN D E. L-Amino acid oxidase of Proteus vulgaris[J]. Journal of Biological Chemistry, 1944, 153(2):387-399.
[35] MOUSTAFA I M, FOSTER S, LYUBIMOV A Y, VRIELINK A. Crystal structure of LAAO from Calloselasma rhodostoma with an L-phenylalanine substrate:insights into structure and mechanism[J]. Journal of Molecular Biology, 2006, 364(5):991-1002.
[36] GEUEKE B, HUMMEL W. A new bacterial l-amino acid oxidase with a broad substrate specificity:purification and characterization[J]. Enzyme and Microbial Technology, 2002, 31(2):77-87.
[37] SUN M Z, GUO C, TIAN Y, et al. Biochemical, functional and structural characterization of Akbu-LAAO:a novel snake venom L-amino acid oxidase from Agkistrodon blomhoffii ussurensis[J]. Biochimie, 2010, 92(4):343-349.
[38] YANG H, JOHNSON P M, KO K C, et al. Cloning, characterization and expression of escapin, a broadly antimicrobial FAD-containing L-amino acid oxidase from ink of the sea hare Aplysia californica[J]. Journal of Experimental Biology, 2005, 208(18):3609-3622.
[39] 祝玉洪, 刘龙, 周景文, 等. 不透明红球菌转化合成α-酮异己酸培养基优化[J]. 生物加工过程, 2011, 9(6):6-10. ZHU Yuhong, LIU Long, ZHOU Jingwen, et al. Medium optimization for biosynthesis of α-ketoisocaproate by Rhodococcus opacus DSM 43250[J]. Chinese Journal of Bioprocess Engineering, 2011, 9(6):6-10.
[40] 祝玉洪. 不透明红球菌生物合成α-酮异己酸的研究[D]. 无锡:江南大学, 2010. ZHU Yuhong. Study on α-ketoisocaproate biosynthesis by Rhodococcus opacus DSM 43250[D]. Wuxi:Jiangnan University, 2010.
[41] ROSINI E, MELIS R, MOLLA G, et al. Deracemization and stereoinversion of α-amino acids by L-amino acid deaminase[J]. Advanced Synthesis and Catalysis, 2017, 359:3373-3781.
[42] DUERRE J A, CHAKRABARTY S. L-amino acid oxidases of Proteus rettgeri[J]. Journal of Bacteriology, 1975, 121(2):656.
[43] BAEK J O, SEO J W, KWON O, et al. Expression and characterization of a second L-amino acid deaminase isolated from Proteus mirabilis in Escherichia coli[J]. Journal of Basic Microbiology, 2011, 51(2):129-135.
[44] TAKAHASHI E, ITO K, YOSHIMOTO T. Cloning of L-amino acid deaminase gene from Proteus vulgaris[J]. Bioscience, Biotechnology, and Biochemistry, 1999, 63(12):2244.
[45] SONG Y, LI J, SHIN H D, et al. One-step biosynthesis of α-ketoisocaproate from L-leucine by an Escherichia coli whole-cell biocatalyst expressing an L-amino acid deaminase from Proteus vulgaris[J]. Scientific Reports, 2015, 5:12614.
[46] SONG Y, LI J, SHIN H D, et al. Tuning the transcription and translation of L-amino acid deaminase in Escherichia coli improves α-ketoisocaproate production from L-leucine[J]. PLoS One, 2017, 12(6):e0179229.
[47] HOU Y, HOSSAIN G S, LI J, et al. Metabolic engineering of cofactor flavin adenine dinucleotide (FAD) synthesis and regeneration in Escherichia coli for production of α-keto acids[J]. Biotechnology and Bioengineering, 2017, 114(9):1928-1936.